Background: The OneTouch Verio Flex® (OTVF) meter with a 3-Color Range Indicator instantly sends readings by Bluetooth® to the OneTouch Reveal® (OTR) app. We sought to provide evidence that these products support improved glycemic control.

Methods: Anonymous glucose and app analytics were extracted from the LifeScan server for 100650 people with type 2 diabetes (T2D) and 20324 people with type 1 diabetes (T1D) . Data from their first 14 days was compared to 14 days prior to a 90 day timepoint using paired within-subject differences.

Results: Percentage glucose readings in-range (70-180mg/dl) improved by 8.7% (from 69.9 to 78.5%) in T2Ds and by 4.0% (from 56.1 to 60.1%) in T1Ds. Hyperglycemic readings (>180mg/dl) reduced by -8.8% (from 28.4 to 19.7%) in T2Ds and by -4.3% (from 38.4 to 34.0%) in T1Ds. Mean glucose reduced on average by -14.1mg/dl (from 160.6 to 146.5mg/dl) in T2Ds and by -6.7mg/dl (from 176.7 to 170.1mg/dl) in T1Ds. Just 4 to 10 sessions per week or 20 to 60 minutes per week on the OTR app improved readings in-range in T2Ds by 9% or 10%, respectively (see graphs below) . Similar trends were observed in people with T1D.

Conclusion: Real world data from over 120000 people with diabetes demonstrates significantly improved data in-range and lower mean glucose in those using the OneTouch Verio Flex® meter and OneTouch Reveal® app.


M. Grady: Employee; LifeScan. H. Cameron: None. E. H. Holt: Employee; Intarcia Therapeutics, Inc., LifeScan.

Readers may use this article as long as the work is properly cited, the use is educational and not for profit, and the work is not altered. More information is available at